ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE

Product NDC

57297-286

11-digit product format

572970286

Labeler code

57297

Product ID

57297-286_24150f6d-980b-4a8f-bf76-6308c091ed56

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE

Dosage form

TABLET

Route

ORAL

Labeler

LUPIN LIMITED

Application

ANDA202912

Marketing category

ANDA

Marketing start

2013-12-17

Marketing end

0000-00-00

Substance

LAMIVUDINE; ZIDOVUDINE; ABACAVIR SULFATE

Active strength

150 mg/1; mg/1; mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]

NDC exclude flag

E

Listing certified through

2017-12-31

Current FDA listing

Historical FDA.report record